TBC3486
CAS No. 247044-77-5
TBC3486 ( TBC-3486;TBC 3486 )
Catalog No. M13721 CAS No. 247044-77-5
A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1053 | Get Quote |
|
50MG | 2142 | Get Quote |
|
100MG | 2790 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTBC3486
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM.
-
DescriptionA potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM, displays 200-fold selectivity over α4β7 (IC50=2.1 uM); mimics VCAM-1 binding, preferentially inhibits the high-affinity form of the integrin α4, blocks integrin-dependent T-cell co-activation in vitro as well as proves to be efficacious in vivo at low doses in animal models of allergic inflammation; dose-dependently inhibits adhesion of ALL cells, prolongs the survival of xenotolerant mice bearing human leukemia cells in vivo.Asthma Discontinued
-
SynonymsTBC-3486;TBC 3486
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number247044-77-5
-
Formula Weight557.68
-
Molecular FormulaC27H31N3O6S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCC(C(=O)N(CC1=CC=CS1)CC2=CC=CS2)NC(=O)NC(CC(=O)O)C3=CC4=C(C=C3)OCO4
-
Chemical Name(S)-3-(benzo[d][1,3]dioxol-5-yl)-3-(3-((S)-1-(bis(thiophen-2-ylmethyl)amino)-1-oxohexan-2-yl)ureido)propanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hsieh YT, et al. Leukemia. 2014 Oct;28(10):2101-4.
2. Vanderslice P, et al. Biochem Biophys Res Commun. 2010 Oct 1;400(4):619-24.
2. Vanderslice P, et al. Biochem Biophys Res Commun. 2010 Oct 1;400(4):619-24.
molnova catalog
related products
-
BIO1211
BIO1211 (BIO-1211) is a potent, highly specific integrin α4β1 (VLA-4) inhibitor with Kd/IC50 of 20 pM/4 nM for the activated form of α4β1.
-
ALG1001
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.
-
LDV
α4β1 integrin (VLA-4) ligand (Kd ~ 12 nM). Non-fluorescent derivative of LDV FITC.